Guest guest Posted August 10, 2010 Report Share Posted August 10, 2010 The University of South Florida-AITRP, USA and The National AIDS Research Institute, Pune, India Announce the Conference on Translational Research in HIV/AIDS in India (TRAI) 12 - 15 January 2011Vivanta by Taj - Goa, India Early Registration: 9/15/2010 Abstract Submission Deadline: 9/15/2010 The mission of the TRAI Conference is to bring together all HIV/AIDS International Training Research Programs working in India for the purpose of training established and new to the field scientists by sharing the latest information on basic and translational aspects of HIV/AIDS relevant to India and creating conditions conducive for networking and collaboration among these groups and maximizing HIV research and training agenda in the Indian subcontinent. Translational Research is the movement of discoveries in basic research to applications at the clinical level. To ensure new discoveries lead to improved public health, clinical science needs to implement biomedical discoveries; develop, test, and bring new prevention strategies into medical practice more rapidly; catalyze change - lower barriers between disciplines; and encourage creative and innovative approaches. There remains a huge gap in translating research conducted in developed nations to the HIV epidemic in underdeveloped and developing countries and presents unique challenges. In this first TRAI US-India Conference the goal is to discuss the advances in basic and clinical research and how they can be translated in India. TRAI conference will have two major tracks: a basic track and a translational track. Keynote addresses and papers will highlight the work of regional prevention research scientists, policymakers, and Indian-U.S. research partnerships, practitioners with evaluated programs or running programs with potential for evaluation. Proposed Conference Agenda Day 1 - WEDNESDAY (Jan 12, 2011) 4:00pm - 6:00 pm: Opening Plenary Session · HIV a Global Perspective · The US HIV Research Agenda-Vision for NIAID · The India HIV Research Agenda-the ICMR Perspective · ICMR/Government initiatives in Prevention · Community-based care and prevention initiatives Day 2 - THURSDAY (Jan 13, 2011) Session I: Epidemiology Session II: New Frontiers in HIV Biology Session III: HIV Immunology Session IV: Opportunistic Infections in AIDS Patients Day 3 - FRIDAY (Jan 14, 2011) Session I: HIV Vaccines Session II: Microbicides Session III: POC Diagnostics Session IV: Preventing HIV Transmission in Children Session V: The Future of HIV Therapeutic Research Day 4 - SATURDAY (Jan 15, 2011) (Post-Conference Workshop) Making sense of evidence: What works and what does not Session I: Matching study design to research question Session II: Critical appraisal skills Only for Pre-selected participants and scholarship recipients (Max 50) Chairpersons USA Chairperson: Dr. Shyam S. Mohapatra, PhD. Mabel & Ellsworth Professor & Co-Director-USF AITRP; Director, Division of Translational Medicine-Nanomedicine Research Center, USF Tampa Email: smohapat@... India Co-Chairperson: Dr. Ramesh Paranjape, PhD Director of National AIDS Research Institute, Dept. of Clinical Science, Pune, India Email: director@... Coordinator: Eknath Naik, MD, PhD, Email: enaik@... Ph: 813-842-8560 Organizing Committee Members USA · Sten Vermund, Vanderbilt University, Nashville, TN · Bollinger, Hopkins University, Baltimore · Detels, University of California, Los Angeles, CA · Emmanuel, University of South Florida, Tampa, FL · Phalguni Gupta, University of Pittsburg, PA · Suman Laal, New York University Sch. of Medicine, New York City, NY · Mayer, Brown University, Providence, RI · Eknath Naik, University of South Florida, Tampa, FL · Vinayaka Prasad, Albert Einstein Coll. of Med., New York City, NY India · Yogesh S. Marfatia, Medical College, Vadodara · Atul K. Patel, Vedanta Institute, Ahmadabad · Vijay Shah, Indu Health Research Foundation, Baroda · Suniti , Y.R.G. Care, Chennai, · N. Kumaraswamy, Y.R.G. Care, Chennai Local Host and Collaborator in Goa Community Resource Foundation · Dr. Anita Dudhane, email:ardudhs@... · Dr. Ajay Pednekar · Mr. Sanjay Naik Confirmed Speakers Arthur Reingold, Univ of Calif. Berkeley, CA, USA Atul Patel, Ahmadabad, India Carey Farquahar, Univ. of Washington, Seattle, USA Beyrer, s Hopkins Univ, Baltimore, MD Weiner, U.Penn, Philadelphia Eknath Naik, Univ of South Florida, Tampa, USA G. Kang, CMC Vellore, India Hanna , Albert Einstein Coll. of Med, NY Ian McGowan, Univ of Pittsburgh, PA, USA W. Sleasman, Univ of South Florida, Tampa, USA Mayer, Brown Univ., MA, USA Lee on, Univ. of Pittsburgh, PA, USA Maureen Goodenow, Univ of Florida, Gainesville, FL N. Chandhiok, ICMR, New Delhi, India N. Kumarswamy, YRG Care, Chennai, India P. Balakrishnan, YRG Care, Chennai, India Emmanuel, Univ of South Florida, Tampa, USA Flynn, St. Jude Children's Research Hospital, TN Krogstad, Reagan UCLA, CA, USA Phalguni Gupta, Univ. of Pittsburgh, PA, USA R. Gangakhedkar, NARI, Pune, India Ramesh Paranjape, Director NARI, India P. Madan, Albert Einstein Coll. of Med, NY C. Bollinger, s Hopkins Univ, BC, MD, USA Detels, UCLA, CA, USA Ron Veazey, Tulane University, New Orleans, LA Sanjay Mehendale, NARI, Pune, India Shahin Lockman, UCSF, CA, USA Shrikant Tripathy, NARI, Pune, India Shyam Mohapatra, Univ of South Florida, Tampa, USA Subhra Mohapatra Univ of South Florida, Tampa, USA Suman Laal, NYU Sch. Of Med., NY Sunil Ahuja, UTHSC, San , TX, USA Suniti , YRG Care, Chennai, India Vikrant Sahasrabddhe, Vanderbilt Univ, Nashville, TN Vinayaka Prasad, Albert Einstein Coll. of Med, NY Guidelines for Abstracts Submission General Information Abstracts should be submitted electronically, using the guidelines below to Alberto Aguilera (aaguiler@...) on or before September 15th,2010. Abstracts should be in Arial, 12 point, typeface, with the title in boldface. The name of the presenting author should be underlined. The abstract text is limited to 250 words and the entire submission must fit on a single page. Questions may be directed to the Conference Coordinator, Alberto Aguilera aaguiler@... Abstract Title The abstract should have a short, specific title (containing no abbreviations) that indicates the nature of the investigation. Title should be in boldface font. Author Name(s) · The name of the primary/presenting author should be underlined. · Individuals should not submit more than one abstract as presenting author. · There is no limit to the number of abstracts an author's name may appear on. Abstract Text · Abstracts should be structured and organized to include the following: o Background/rationale o Methods o Results o Conclusion · Use generic drug names (brand name may be included in parentheses). · Do not begin sentences with numerals. · Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated. · Abstracts are limited to 250 words. This includes the text plus any graphic/table, but not the title or authors. The entire submission must fit on one page. Presentation · Guidelines for abstract presentation (poster) will be provided to authors. Traps to Avoid 1. Typographical errors are irritating to most readers. 2. Don't cite references in the abstract. 3. Provide some context/statement of relevance that provides the rationale for your study. 4. Don't use complex graphics. Simple line or bar graphs work best. Make sure the font is adequate on each axis to be seen. Check a printed version of the abstract before submission. Don't leave abstract writing until the 11th hour -- this increases stress and leads to errors. For Registration form and Other details including registration fees contact: Alberto Aguilera University of South Florida 12901 Bruce B. Downs Blvd.MDC 19, Tampa, FL 33617 aaguiler@... 813-974-8565 (fax) Webpage: http://health.usf.edu/research/aitrip/trai.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.